JAZZ vs PG · P/E 1988, rev $4.07B vs P/E 25, rev $84.28B
Jazz Pharmaceuticals PLC (JAZZ) versus Procter & Gamble Company (PG) — a side-by-side from cached financials, not a winner call.
Jazz Pharmaceuticals PLC (JAZZ) is a biotechnology company listed on US.
Procter & Gamble Company (PG) is a household & personal products company listed on US. It is led by Jon Moeller.
Latest reported JAZZ revenue for 2024-12-31 was $4.07B. Net income was $560.1M. Revenue was up 6.1% from 2023-12-31 to 2024-12-31. JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1.
Latest reported PG revenue for 2025-06-30 was $84.28B. Net income was $15.97B. PG currently screens at market cap $373.53B and trailing P/E 25.3.
JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1. PG currently screens at market cap $373.53B and trailing P/E 25.3.
Not investment advice. Open the JAZZ and PG stock pages for the full models.
Not investment advice.